The pharmaceutical industry and the “off-label marketing” of drugs will be addressed in an ethics presentation at DeSales University from 6:00 p.m. to 7:00 p.m., Wednesday, February 24, in the Priscilla Payne Hurd Science Center Auditorium. The featured speaker, Jim Pepper ’91, an attorney with the Elliott Greenleaf Law Firm in Philadelphia, will speak on “Pharmaceutical Marketing: Legal and Ethical Issues.” The program is open to the public free of charge.
In “off-label marketing,” a company promotes drugs for uses the FDA has not approved. The pharmaceutical giant Pfizer, Inc. was fined $1.2 billion by the U.S. Justice Department when it ignored FDA warnings. It was the largest criminal fine in U.S. history ever paid by a drug company for defrauding the government’s Medicare and Medicaid programs. In his talk, Pepper, one of the attorneys in the case, will provide an analysis of the case.
The talk is sponsored by the Fleming Institute for Business Ethics at DeSales, in collaboration with DeSales University Department of Business and the Salesian Center for Faith and Culture. For more information, please contact the department of business at DeSales at 610-282-1100, ext. 1244.
Press Release: Pharmaceuticals and off-label drug marketing, focus of ethics presentation | Posted on: 2/23/2010
For more info:
Tom McNamara, Executive Director of Communications
DeSales University | 2255 Station Avenue | Center Valley, PA 18034
610.282.1100 x1219 | Tom.McNamara@desales.edu